腹会阴切除术
医学
新辅助治疗
放化疗
外科
化疗
癌症
结直肠癌
内科学
乳腺癌
作者
Machiko Nagata,Takeru Matsuda,Hiroshi Hasegawa,Masako Utsumi,Kimihiro Yamashita,Masashi Yamamoto,Shingo Kanaji,Taro Oshikiri,Tetsu Nakamura,Satoshi Suzuki,Yoshihiro Kakeji
出处
期刊:Anticancer Research
[International Institute of Anticancer Research (IIAR) Conferences 1997. Athens, Greece. Abstracts]
日期:2020-10-27
卷期号:40 (11): 6539-6543
被引量:6
标识
DOI:10.21873/anticanres.14678
摘要
Omentoplasty is sometimes used to prevent perineal wound complications after abdominoperineal resection (APR) following neoadjuvant chemoradiotherapy (NACRT). However, recent studies have raised some controversy about its clinical benefit.Outcomes for rectal cancer patients who received APR after NACRT were retrospectively compared between the groups with omentoplasty (n=28) and without omentoplasty (n=14).The operative time was significantly longer in the omentoplasty group (575 vs. 404 min, p<0.001). Laparoscopic surgery was performed more frequently in the omentoplasty group. Perineal wound problems including dehiscence and infection were significantly reduced in the omentoplasty group (46.4% vs. 78.6%, p<0.001). Univariate and multivariate analyses revealed that omentoplasty was the most important factor in reducing perineal wound complications (odds ratio=0.020, 95% confidence intervaI=0.001-0.393; p=0.001).Omentoplasty was useful in reducing perineal wound complications after APR following NACRT.
科研通智能强力驱动
Strongly Powered by AbleSci AI